Atom completes £1.75m commercial mortgage for property investor

Atom bank, has supported an experienced property investor with a £1.75m commercial mortgage, allowing them to expand their portfolio.

The case was introduced by Jeremy Robinson, director of Aquilae Capital Advisory, with the loan secured against a light industrial unit on the London/Essex border, at 60% LTV.

The deal has allowed the borrower to release capital to support the acquisition of further light industrial units, with exchange due to take place imminently on the first of these purchases.

Atom bank has recently updated its commercial lending proposition, introducing a rate discount for high debt service cover cases and reducing its minimum loan size to £100,000.

The lender has also increased its procuration fee to 1.75% for commercial lending applications submitted between 8 June and 30 September. The overall arrangement fee charged to borrowers remains 2.00%, with Atom reducing its retained share.

In addition it has reduced rates by 0.40% for loans between £1m and £3m and 0.25% for loans above £3m up to £10m.

Neil Findlay, regional business development manager at Atom bank, commented: “Experienced investors are looking again at expanding their portfolios, but in order to do so they need support from lenders who truly understand this market.

“Atom bank has a great reputation for our expertise within specific sectors of the commercial space, including industrial properties, and our ability to deliver bespoke funding based on the individual client’s circumstances.”

Jeremy Robinson, director of Aquilae Capital Advisory, added: “We are already engaged with the client on a further transaction and look forward to working with them again to support their continued growth of their property portfolio and wider investment ambitions.

“Atom bank was the perfect partner for this case, taking the time to understand what the client was looking to achieve and deliver a really competitive fixed rate and a structure that worked brilliantly for the client.”

Related Articles

Latest News